Tracking the WDNA expected move helps you see how far WisdomTree BioRevolution Fund's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. WisdomTree BioRevolution Fund's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the WDNA expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For WDNA, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The WDNA expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks WisdomTree BioRevolution Fund is unlikely to go.
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the WDNA expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The WisdomTree BioRevolution Fund expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about WDNA.
